Atricure Inc
Atricure Inc (ATRC) Covered Calls
As of September 21, 2026, ATRC has 12 covered call opportunities in the coming three months. Return ranges from 5.2 to 38.0% until expiration. Annualized return ranges from 23.3 to 89.5%. The nearest expiration is October 16, 2026. Maximum potential profit is $2,205.
Read more
Running ATRC covered calls helps you generate consistent income from Atricure Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Atricure Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ATRC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ATRC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ATRC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Atricure Inc covered call is worth writing.
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation.
It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Income-focused investors, long-term ATRC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ATRC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Atricure Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Instruments & Supplies
- SectorHealthcare
- IV percentile21.83% Subdued
- Market cap (M$)2,967
- 52 weeks high-2.61%
- 52 weeks low129.97%
- Analyst recommendationStrong Buy
1.40 - Target price$53.33
-8.56% below the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E269.38
- Future P/E139.30
- EPS (ttm)0.22
- EPS growth next 5 years—
As of September 21, 2026
| 2027-01-15 | 119 | 75.00 | 29.09 | 0.05 | 4.90 | 1695.00 | 29.17 | 89.48 | -0.09 | +0.26 | 0 | 4.85 |
| 2026-11-20 | 63 | 65.00 | 11.88 | 0.25 | 5.00 | 715.00 | 12.31 | 71.30 | -0.43 | +0.35 | 0 | 4.75 |
| 2026-10-16 | 28 | 60.00 | 3.27 | 1.10 | 4.90 | 300.00 | 5.16 | 67.31 | -1.89 | +0.46 | 2 | 3.80 |
| 2027-04-16 | 210 | 80.00 | 37.69 | 0.15 | 4.90 | 2205.00 | 37.95 | 65.96 | -0.26 | +0.25 | 0 | 4.75 |
| 2027-01-15 | 119 | 70.00 | 20.48 | 0.20 | 4.90 | 1210.00 | 20.83 | 63.88 | -0.34 | +0.30 | 0 | 4.70 |
| 2027-04-16 | 210 | 75.00 | 29.09 | 1.15 | 5.50 | 1805.00 | 31.07 | 54.00 | -1.98 | +0.31 | 1 | 4.35 |
| 2027-01-15 | 119 | 65.00 | 11.88 | 1.35 | 6.00 | 825.00 | 14.20 | 43.55 | -2.32 | +0.40 | 0 | 4.65 |
| 2027-04-16 | 210 | 70.00 | 20.48 | 2.15 | 6.50 | 1405.00 | 24.18 | 42.03 | -3.70 | +0.38 | 0 | 4.35 |
| 2026-11-20 | 63 | 60.00 | 3.27 | 2.05 | 6.50 | 395.00 | 6.80 | 39.39 | -3.53 | +0.49 | 0 | 4.45 |
| 2027-04-16 | 210 | 65.00 | 11.88 | 3.80 | 8.50 | 1070.00 | 18.42 | 32.01 | -6.54 | +0.47 | 1 | 4.70 |
As of September 21, 2026
Sell covered calls with the data behind you
Find the best ATRC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→